Ishwarlal Jialal1, Sridevi Devaraj, Beverley Adams-Huet, Xinpu Chen, Harmeet Kaur. 1. Department of Pathology and Laboratory Medicine, University of California at Davis, Medical Center, 4635 Second Avenue, Research 1 Building, Room 3000, Sacramento, California 95817, USA. ijialal@ucdavis.edu
Abstract
CONTEXT: Metabolic syndrome (MetS) confers a greater risk for both cardiovascular disease (CVD) and diabetes. Oxidative stress (OS) could contribute to this excess risk. However, there are few data examining both cellular and circulating biomarkers of OS in MetS uncomplicated by diabetes and CVD. OBJECTIVE: The aim of the study was to evaluate both cellular and circulating biomarkers of OS in MetS uncomplicated by diabetes or CVD. DESIGN AND SETTING: At an academic medical center, we compared MetS (n=43) vs. control subjects (n=33). Fasting blood was collected for monocyte isolation and assay of OS biomarkers. MAIN OUTCOME: Monocyte nicotinamide adenine dinucleotide phosphate oxidase activity (p22 phox and p47), superoxide anion release, oxidized-low-density lipoprotein (Ox-LDL), nitrotyrosine, and nuclear factor erythroid 2-related factor were measured. RESULTS: There was significantly increased release of superoxide from the monocytes (basal and after activation) of MetS compared with controls adjusted for body mass index. Body mass index-adjusted plasma levels of Ox-LDL and nitrotyrosine were significantly increased in MetS. There was a linear trend between biomarkers of oxidative stress and increasing number of features of MetS. Also, there was a significant increase in nicotinamide adenine dinucleotide phosphate oxidase membrane expression of p22 phox and p47 phox in MetS. The major cellular antioxidant defense, nuclear factor erythroid 2-related factor was significantly decreased. There were significant correlations between homeostasis model assessment insulin resistance index and both Ox-LDL and nitrotyrosine and superoxide and Ox-LDL. CONCLUSIONS: Collectively, nascent MetS is associated with increased OS as evidenced by both circulating and cellular biomarkers, and this could contribute to the risk for both diabetes and CVD.
CONTEXT: Metabolic syndrome (MetS) confers a greater risk for both cardiovascular disease (CVD) and diabetes. Oxidative stress (OS) could contribute to this excess risk. However, there are few data examining both cellular and circulating biomarkers of OS in MetS uncomplicated by diabetes and CVD. OBJECTIVE: The aim of the study was to evaluate both cellular and circulating biomarkers of OS in MetS uncomplicated by diabetes or CVD. DESIGN AND SETTING: At an academic medical center, we compared MetS (n=43) vs. control subjects (n=33). Fasting blood was collected for monocyte isolation and assay of OS biomarkers. MAIN OUTCOME: Monocyte nicotinamide adenine dinucleotide phosphate oxidase activity (p22 phox and p47), superoxide anion release, oxidized-low-density lipoprotein (Ox-LDL), nitrotyrosine, and nuclear factor erythroid 2-related factor were measured. RESULTS: There was significantly increased release of superoxide from the monocytes (basal and after activation) of MetS compared with controls adjusted for body mass index. Body mass index-adjusted plasma levels of Ox-LDL and nitrotyrosine were significantly increased in MetS. There was a linear trend between biomarkers of oxidative stress and increasing number of features of MetS. Also, there was a significant increase in nicotinamide adenine dinucleotide phosphate oxidase membrane expression of p22 phox and p47 phox in MetS. The major cellular antioxidant defense, nuclear factor erythroid 2-related factor was significantly decreased. There were significant correlations between homeostasis model assessment insulin resistance index and both Ox-LDL and nitrotyrosine and superoxide and Ox-LDL. CONCLUSIONS: Collectively, nascent MetS is associated with increased OS as evidenced by both circulating and cellular biomarkers, and this could contribute to the risk for both diabetes and CVD.
Authors: Xiao-Yuan Dai Perrard; Zeqin Lian; George Bobotas; Mary R Dicklin; Kevin C Maki; Huaizhu Wu Journal: J Clin Lipidol Date: 2017-08-26 Impact factor: 4.766
Authors: Alfonso Eirin; John R Woollard; Christopher M Ferguson; Kyra L Jordan; Hui Tang; Stephen C Textor; Amir Lerman; Lilach O Lerman Journal: Transl Res Date: 2017-03-11 Impact factor: 7.012
Authors: Rocio de la Iglesia; Patricia Lopez-Legarrea; Paloma Celada; Francisco J Sánchez-Muniz; J Alfredo Martinez; M Angeles Zulet Journal: Int J Mol Sci Date: 2013-03-27 Impact factor: 5.923
Authors: Anh Vu; Maha S Sidhom; Brooke C Bredbeck; Lisa A Kosmiski; Christina L Aquilante Journal: Diabetol Metab Syndr Date: 2014-01-15 Impact factor: 3.320
Authors: Maria Del Ben; Francesco Angelico; Roberto Cangemi; Lorenzo Loffredo; Roberto Carnevale; Teresa Augelletti; Francesco Baratta; Licia Polimeni; Pasquale Pignatelli; Francesco Violi Journal: ISRN Obes Date: 2012-11-06